Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to conduct a review of JCVI eligibility criteria and to reinstate free Covid‑19 vaccinations for all clinically vulnerable people, in line with the existing approach to NHS flu vaccinations.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 vaccination programme remains the prevention of serious illness, resulting in hospitalisations and deaths, arising from COVID-19.

The JCVI has advised that population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.

The focus of the JCVI advised programme has moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed.

The Government has accepted the JCVI advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:

- adults aged 75 years old and over;

- residents in care homes for older adults; and

- individuals aged six months and over who are immunosuppressed, as defined in the ‘immunosuppression’ sections of tables 3 or 4 in the COVID-19 chapter of the UK Health Security Agency Green Book.

Although seasonal flu and COVID-19 can both cause severe disease, they differ in their epidemiology and pathology. As such, the population groups at higher risk of severe disease will not necessarily be the same for each pathogen and the JCVI has considered each programme individually.

The JCVI keeps all vaccination programmes under review.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment she has made of the implications for her policies of reports of UK arms export licences being linked to the conflict in Sudan; and whether she plans to suspend any UK arms export licences linked to arms use in Sudan, including via intermediaries.

Answered by Chris Elmore - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

I refer the Hon. Member to the responses provided in the Urgent Question debate on the Conflict in Sudan on 5 November 2025, where these issues were discussed at length.

Found: Watch the meeting Members present: Emily Thornberry (Chair); Fleur Anderson; Alex Ballinger; Aphra Brandreth

Found: Watch the meeting Members present: Emily Thornberry (Chair); Fleur Anderson; Alex Ballinger; Aphra Brandreth

Found: Watch the meeting Members present: Emily Thornberry (Chair); Fleur Anderson; Aphra Brandreth; Phil Brickell

Found: Watch the meeting Members present: Emily Thornberry (Chair); Fleur Anderson; Aphra Brandreth; Phil Brickell

Found: Watch the meeting Members present: Emily Thornberry (Chair); Fleur Anderson; Aphra Brandreth; Phil Brickell

Found: Watch the meeting Members present: Emily Thornberry (Chair); Fleur Anderson; Alex Ballinger; Aphra Brandreth

Found: Watch the meeting Members present: Emily Thornberry (Chair); Fleur Anderson; Alex Ballinger; Aphra Brandreth